Capillary electrophoresis system BioPhase 8800

The BioPhase 8800 system is a multi-capillary electrophoresis system that enables biopharma scientists to run multiple samples in parallel, accelerating the development and execution of sensitive, high-throughput analytical methods. The increased throughput and reproducibility of the system minimizes bottlenecks in the drug development pipeline, helping shorten time to market. Check out the newly added capability for fast glycan analysis on the BioPhase 8800 system by navigating below: Multiply your results. Multiply your success. Accelerate the development of your biotherapeutics. Innovated from the ground up, the BioPhase 8800 system helps biopharmaceutical labs take charge of their development pipelines. Scientists can now assess molecular liabilities more quickly, allowing rapid developability assessments to streamline the selection of candidates to be progressed into an effective therapy. Features Run more samples, and more molecules, on a single system through not 1, but 8 capillaries in parallel. Existing approaches to detect and characterize changes during development of monoclonal antibodies (mAbs), next-generation therapeutics and gene therapies are challenged to deliver the detailed information you need in the time you need it. The BioPhase 8800 system facilitates parallel processing of 8 samples simultaneously, while retaining the capability to deliver sensitive capillary electrophoresis sodium dodecyl sulfate (CE-SDS), ribonucleic acid (RNA), capillary isoelectric focusing (cIEF) and glycan characterization analysis, enabling uncompromised accuracy for large sample sets and faster time to answers.